Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
20 Cards in this Set
- Front
- Back
|
Yellow Book |
CDC resource |
|
|
traveler's diarrhea |
Asia, Middle East, Africa, Mexico, Central and South America 3+ unformed stools/day + cramping, N/V E.coli untreated: 3-7 days |
|
|
traveler's diarrhea prophylaxis |
bismuth subsalicylate |
|
|
traveler's diarrhea treatment |
hydration increased salt intake loperamide 4 mg after 1st loose stool, then 2 mg after each subsequent day -max 8 mg/day for up to 2 days bismuth subsalicylate abx (quinolones, marolides) if moderate - severe |
|
|
typhoid fever |
salmonella Asia, Africa, Caribbean, Central/South America food/water contaminated w/ feces, acute infection carrier, or chronic asymptomatic carrier incubation period: 6-30 days fatigue, fever increasing over 3-4 days, HA, malaise, anorexia, enlargement of liver/spleen, transient rash |
|
|
typoid fever vaccines |
vivotif (live, oral) typhim Vi (inactivated, IM -2 weeks before exposure 50-80% effective- wash hands frequently and be careful with food/water |
|
|
cholera |
vibrio cholerae Africa, Southeast Asia, Haiti diarrhea ("rice water stools), vomiting, dehydration |
|
|
cholera vaccine |
vaxchora live single, oral liquid dose >10 days before travel |
|
|
hepatitis A |
traveling to developing countries fever, malaise, jaundice, nausea, abdominal discomfort up to 7 weeks |
|
|
hepatitis B |
contaminated blood or bodily fluids incubation period 90 days malaise, jaundice, nausea, abdominal discomfort 3 dose vaccine - 6 months to complete -may complete as many doses as possible before departure and finish upon return -high risk: accelerated series |
|
|
meningococcal meningitis |
n. meningitidis fever, severe headache, nausea, stiff neck Africa December-June, Saudi Arabia during Hajj and Umrah pilgrimage quadrivalent vaccine |
|
|
Polio |
Afghanistan, Burma (Myanmar), Guinea, Laos, Nigeria, Madagascar, Pakistan, Ukraine if spending > 4 weeks there, 1 time booster at least 4 weeks prior to travel |
|
|
insect bites |
20-50% DEET permethrin for clothing, gear, bed nets |
|
|
dengue |
mosquitos no vaccine treatment: supportive care |
|
|
malaria |
Asia, Latin America, North Africa, Eastern Europe, South Pacific P. vivax = 50% of cases in India P. falciparum = most deadly |
|
|
Malaria Prophylaxis |
Atovaqone/Proguanil (Malarone) 250/100 mg PO daily w/ food or milk start 1-2 days pre-travel, stop 7 days post do not use in pregnancy or CrCl <30 Primaquine 30 mg PO daily w/ food (nausea) start 1 day pre-travel stop 7 days post do not use if G6PD deficiency or pregnancy Mefloquine (Larium) 250 mg PO weekly w/ food/water start 2-3 weeks pre-travel stop 4 weeks post do not use w/ neuropsychiatric disorders OK in pregnancy Chloroquine (Aralen) 500 mg PO weekly w/food start 1-2 weeks pre-travel stop 4 weeks post CrCl < 10: use 50% dose OK in pregnancy Doxycycline (Vibramycin) 100 mg daily w/ food start 1-2 weeks pre-travel, stop 4 weeks post OK in pregnancy |
|
|
Japanese Encephalitis |
mosquitos vaccine: Ixiaro for travelers > 2 months who plan to spend at least 1 month in endemic areas during season |
|
|
Yellow fever |
tropical areas in South America and Africa mosquitos asymptomatic or flu-like symptoms do not use aspirin or NSAIDs vaccine: single dose = lifelong protection -high risk of adverse effects: fever, headache, neurologic disease -CI in patients w/ hypersensitivity to eggs |
|
|
Zika |
mosquito, sexual, blod transfusion
fever, maculopapular rash, arthralgia, conjuntivitis No vaccine yet |
|
|
Motion sickness |
acetazolamide (diamox) 125 mg BID, started the day before or day of ascent prophylaxis for mountain sickness CI w/ sulfa allergy |
